views
3:33
Dr. César Galo- Biongineering, Orthopedics and Surgery in Pediatrics group at VHIR
42:08
Informative Session Master in Health & Science Management
0:38
The benefits of mpMRI over conventional MRI imaging in oncology
1:22
Biomarkers of response to OMO-103, a novel MYC inhibitor
0:57
The pharmacodynamics of the pan-MYC inhibitor OMO-103
1:02:54
Sino-International Dialogue on Bone and Soft-tissue Tumor Standard of Care
0:49
The future of mpMRI-based biomarkers in enhancing ICI efficacy
43:14
Killing cancer cells by targeting glucose metabolism
